Status:
UNKNOWN
Bone Quality Lyon Orleans
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Osteopenic Women
Eligibility:
FEMALE
50+ years
Brief Summary
QUALYOR is a prospective study on the predictive value for fragility fracture of various new techniques assessing bone quality, among postmenopausal women with low bone mass.
Eligibility Criteria
Inclusion
- 50 or older women
- post-menopausal since at least one year
- with osteopenia (T-score between -1.0 and -2.5 (with clinical factor risk) or -3.0 (without clinical factor risk)
Exclusion
- corticosteroid therapy \> 3 months, at least 7.5mg/day equivalent prednisolon (stopped since at least 1 year)
- osteoporosis treatment antecedent
- fragility fracture antecedent
- on going post-menopausal hormonal treatment
- clinical signs of hepatic, cardiac or respiratory insufficiency, diseases possibly affecting bone metabolism
- life expectancy \< 4 years, mental or serious illness
Key Trial Info
Start Date :
September 20 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
1605 Patients enrolled
Trial Details
Trial ID
NCT01150032
Start Date
September 20 2010
End Date
May 1 2025
Last Update
July 7 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France
2
Centre Hospitalier d'Orléans
Orléans, France